Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

Insights from 2023 IMS Annual Meeting
J

IMS 2023 Insights: "Epigenetic Regulation of CD38/48 by KDM6A and NK Cell Response in MM"

By Insights from 2023 IMS Annual Meeting FEATURING Jiye Liu
By Insights from 2023 IMS Annual Meeting FEATURING Jiye Liu
53 views
October 10, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das
Myeloma
07:41

ASH 2024 Insights: Effectiveness of Immunoglobulin Replacement on Hy…

2024 ASH Annual Meeting Insights Hub

E. O'Donnell

56 views
10:37

ASH 2024 Insights: Cilta-Cel CAR-T in High-Risk SMM - Results From C…

2024 ASH Annual Meeting Insights Hub

O. Nadeem

48 views
15:00

FDA Approval of Isatuximab in 1L MM: Perspectives for Practice

Dana-Farber Cancer Institute

P. Richardson

991 views
19:24

ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - Incorpo…

Insights from 2023 ASH Annual Meeting

P. Richardson

761 views
15:13

ASH 2023 Insights: "Mezigdomide + Dex + Dara or Elo in Pts With R/R …

Insights from 2023 ASH Annual Meeting

P. Richardson

140 views
15:49

SOHO 2023 DEBATE: Early HDM-aSCT in MM Is No Longer the SoC

SOHO 2023 Eleventh Annual Meeting

C. Mo

159 views
16:25

SOHO 2023: Treatment of the Frail MM Patients - Personalized Care

SOHO 2023 Eleventh Annual Meeting

B. O'Donnell

141 views
09:52

IMS 2023 Insights: "Epigenetic Regulation of CD38/48 by KDM6A and NK…

Insights from 2023 IMS Annual Meeting

J. Liu

53 views
11:35

ASCO® 2023 Insights: "Updated Phase I Study Results of PHE885, a T-C…

Insights from 2023 ASCO® Annual Meeting

A. Sperling

237 views
32:03

Emerging and Current Treatment of MM: What Should We Know and What S…

Indy Hematology Review

K. Anderson

653 views
41:46

Early Detection and Interception in Myeloma: The PROMISE Study

Yale Cancer Center

I. Ghobrial

141 views
36:59

Updates on Managing Bone Disease in Multiple Myeloma

Dana-Farber Cancer Institute

M. Hartley-Brown

69 views
23:11

Bispecific Antibodies in Multiple Myeloma

Dana-Farber Cancer Institute

O. Nadeem

200 views
54:12

Symptom Management in Multiple Myeloma

Dana-Farber Cancer Institute

S. Midha

144 views
23:40

Update on CAR T-Cells in Multiple Myeloma

Dana-Farber Cancer Institute

A. Sperling

124 views
34:40

Updates on AL Amyloidosis Treatment: What is New in 2023

Dana-Farber Cancer Institute

G. Bianchi

294 views
48:46

The Ongoing Evolution of Systemic Therapy for ND Multiple Myeloma

Dana-Farber Cancer Institute

C. Mo

26 views
47:04

Future Directions for Novel & Next Gen Therapy in the Management of …

Dana-Farber Cancer Institute

P. Richardson

315 views
20:28

The PROMISE of Early Detection and Interception in Myeloma

Dana-Farber Cancer Institute

I. Ghobrial

214 views
44:49

Recent Updates in Multiple Myeloma

Dana-Farber Cancer Institute

K. Anderson

746 views
26:24

Myeloma 101: Diagnosis, Prognosis & Risk

Dana-Farber Cancer Institute

N. Munshi

504 views
10:37

ASH 2022 Mezigdomide (CC-92480) + Dex in R/R MM: Preliminary Results…

ASH 2022 Conference Coverage

P. Richardson

178 views
10:37

ASH 2022 Subsequent Antimyeloma Therapies From ICARIA-MM Study: Pom/…

ASH 2022 Conference Coverage

P. Richardson

112 views
24:19

Phase 3 DETERMINATION Trial: RVd ± ASCT & Lenalidomide Maintenance t…

Dana-Farber Cancer Institute

P. Richardson

384 views
12:09

2022 Treatment Landscape and Future Directions of R/R Multiple Myelo…

Dana-Farber Cancer Institute

N. Munshi

459 views
08:51

EHA 2020 ICARIA-MM Data on Isatuximab in R/R Multiple Myeloma: Does …

Dana-Farber Cancer Institute

P. Richardson

247 views
06:23

EHA/ASH 2020 Update on mAbs for R/R Multiple Myeloma: Is the Additio…

Dana-Farber Cancer Institute

P. Richardson

169 views
19:38

Waldenström Macroglobulinemia - Standard Treatment Options and Revie…

Dana-Farber Cancer Institute

J. Castillo

257 views
12:07

Waldenström Macroglobulinemia: Diagnostic criteria, Why Not Treat Ev…

Dana-Farber Cancer Institute

J. Castillo

647 views
17:47

Relapse Refractory Myeloma and Novel Treatments

Dana-Farber Cancer Institute

N. S. Raje

246 views
16:28

Is it Time to Treat Patients with Smoldering Myeloma in 2018?

Dana-Farber Cancer Institute

I. Ghobrial

206 views
35:43

2016 Multiple Myeloma Patient Education Symposium: Novel Treatments …

Dana-Farber Cancer Institute

N. S. Raje

123 views